255 related articles for article (PubMed ID: 22054145)
1. Physiology of weight loss surgery.
Park CW; Torquati A
Surg Clin North Am; 2011 Dec; 91(6):1149-61, vii. PubMed ID: 22054145
[TBL] [Abstract][Full Text] [Related]
2. Incretins, diabetes, and bariatric surgery: a review.
Fetner R; McGinty J; Russell C; Pi-Sunyer FX; Laferrère B
Surg Obes Relat Dis; 2005; 1(6):589-97; discussion 597-8. PubMed ID: 16925299
[No Abstract] [Full Text] [Related]
3. Lower ghrelin levels and exaggerated postprandial peptide-YY, glucagon-like peptide-1, and insulin responses, after gastric fundus resection, in patients undergoing Roux-en-Y gastric bypass: a randomized clinical trial.
Chronaiou A; Tsoli M; Kehagias I; Leotsinidis M; Kalfarentzos F; Alexandrides TK
Obes Surg; 2012 Nov; 22(11):1761-70. PubMed ID: 22911148
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms in bariatric surgery: Gut hormones, diabetes resolution, and weight loss.
Holst JJ; Madsbad S; Bojsen-Møller KN; Svane MS; Jørgensen NB; Dirksen C; Martinussen C
Surg Obes Relat Dis; 2018 May; 14(5):708-714. PubMed ID: 29776493
[TBL] [Abstract][Full Text] [Related]
5. Are we closer to finding the treatment for type 2 diabetes mellitus in morbid obesity? Are the incretins the key to success?
Frezza EE
Obes Surg; 2004 Aug; 14(7):999-1005. PubMed ID: 15329192
[TBL] [Abstract][Full Text] [Related]
6. Changes in gastrointestinal hormones and leptin after Roux-en-Y gastric bypass procedure: a review.
Beckman LM; Beckman TR; Earthman CP
J Am Diet Assoc; 2010 Apr; 110(4):571-84. PubMed ID: 20338283
[TBL] [Abstract][Full Text] [Related]
7. [Early improvement in Type 2 diabetes in obese patients following gastric bypass and bilio-pancreatic diversion: the role of the entero-insular axis].
Lifante JC; Inabnet WB
J Chir (Paris); 2008; 145(6):549-55. PubMed ID: 19106885
[TBL] [Abstract][Full Text] [Related]
8. Peptide YY and glucagon-like peptide-1 in morbidly obese patients before and after surgically induced weight loss.
Reinehr T; Roth CL; Schernthaner GH; Kopp HP; Kriwanek S; Schernthaner G
Obes Surg; 2007 Dec; 17(12):1571-7. PubMed ID: 18046613
[TBL] [Abstract][Full Text] [Related]
9. Could the mechanisms of bariatric surgery hold the key for novel therapies? report from a Pennington Scientific Symposium.
Tam CS; Berthoud HR; Bueter M; Chakravarthy MV; Geliebter A; Hajnal A; Holst J; Kaplan L; Pories W; Raybould H; Seeley R; Strader A; Ravussin E
Obes Rev; 2011 Nov; 12(11):984-94. PubMed ID: 21729236
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of disease: the role of gastrointestinal hormones in appetite and obesity.
Vincent RP; Ashrafian H; le Roux CW
Nat Clin Pract Gastroenterol Hepatol; 2008 May; 5(5):268-77. PubMed ID: 18382432
[TBL] [Abstract][Full Text] [Related]
11. Changes in gastrointestinal hormone responses, insulin sensitivity, and beta-cell function within 2 weeks after gastric bypass in non-diabetic subjects.
Jacobsen SH; Olesen SC; Dirksen C; Jørgensen NB; Bojsen-Møller KN; Kielgast U; Worm D; Almdal T; Naver LS; Hvolris LE; Rehfeld JF; Wulff BS; Clausen TR; Hansen DL; Holst JJ; Madsbad S
Obes Surg; 2012 Jul; 22(7):1084-96. PubMed ID: 22359255
[TBL] [Abstract][Full Text] [Related]
12. Hormonal mechanisms of weight loss and diabetes resolution after bariatric surgery.
Cummings DE; Overduin J; Shannon MH; Foster-Schubert KE;
Surg Obes Relat Dis; 2005; 1(3):358-68. PubMed ID: 16925248
[No Abstract] [Full Text] [Related]
13. Gut hormones as mediators of appetite and weight loss after Roux-en-Y gastric bypass.
le Roux CW; Welbourn R; Werling M; Osborne A; Kokkinos A; Laurenius A; Lönroth H; Fändriks L; Ghatei MA; Bloom SR; Olbers T
Ann Surg; 2007 Nov; 246(5):780-5. PubMed ID: 17968169
[TBL] [Abstract][Full Text] [Related]
14. Do Incretins play a role in the remission of type 2 diabetes after gastric bypass surgery: What are the evidence?
Bose M; Oliván B; Teixeira J; Pi-Sunyer FX; Laferrère B
Obes Surg; 2009 Feb; 19(2):217-229. PubMed ID: 18820978
[TBL] [Abstract][Full Text] [Related]
15. Gut-brain communication: how does it stand after bariatric surgery?
de Fátima Haueisen Sander Diniz M; de Azeredo Passos VM; Diniz MT
Curr Opin Clin Nutr Metab Care; 2006 Sep; 9(5):629-36. PubMed ID: 16912562
[TBL] [Abstract][Full Text] [Related]
16. Preoperative assessment of gut hormones does not correlate to weight loss after Roux-en-Y gastric bypass surgery.
Werling M; Fändriks L; Vincent RP; Cross GF; le Roux CW; Olbers T
Surg Obes Relat Dis; 2014; 10(5):822-8. PubMed ID: 25282191
[TBL] [Abstract][Full Text] [Related]
17. Effects of sleeve gastrectomy and gastric banding on the hypothalamic feeding center in an obese rat model.
Kawasaki T; Ohta M; Kawano Y; Masuda T; Gotoh K; Inomata M; Kitano S
Surg Today; 2015 Dec; 45(12):1560-6. PubMed ID: 25724939
[TBL] [Abstract][Full Text] [Related]
18. Entero-endocrine changes after gastric bypass in diabetic and nondiabetic patients: a preliminary study.
Whitson BA; Leslie DB; Kellogg TA; Maddaus MA; Buchwald H; Billington CJ; Ikramuddin S
J Surg Res; 2007 Jul; 141(1):31-9. PubMed ID: 17574036
[TBL] [Abstract][Full Text] [Related]
19. Bariatric surgery for morbid obesity.
Duell PB
JAMA; 2003 Apr; 289(14):1779; author reply 1779. PubMed ID: 12684352
[No Abstract] [Full Text] [Related]
20. Weight Regain After Gastric Bypass: Influence of Gut Hormones.
Santo MA; Riccioppo D; Pajecki D; Kawamoto F; de Cleva R; Antonangelo L; Marçal L; Cecconello I
Obes Surg; 2016 May; 26(5):919-25. PubMed ID: 26450709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
